Fujifilm Holdings Corp - Company Profile
Powered by 
All the sales intelligence you need on Fujifilm Holdings Corp in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Fujifilm Holdings Corp fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Fujifilm Holdings Corp.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Business Description
Fujifilm Holdings Corp (Fujifilm) is involved in the development, production, and sale of imaging, information, and document solutions. The company focuses on developing solutions in prevention, diagnosis, and treatment within healthcare, while also addressing environmental issues and promoting industrial efficiency in electronics. Fujifilm serves a diverse range of sectors, including medical systems, semiconductor materials, business solutions, and consumer imaging.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
Fujifilm's R&D arm focuses on transforming its business through innovation, focusing on creating new technologies and value to replace the declining photographic film market. The company is strengthening technological synergies with its subsidiaries and promoting alliances, mergers, and collaborations with industry, academia, and government. The R&D efforts are structured around developing new businesses and technologies in semiconductor materials, energy materials, and environmental technologies to ensure sustainable growth. The company's R&D activities are managed through two main units: "Divisional Labs," which conduct business-linked R&D directly under each business unit, responsible for research and development of fundamental technologies from a company-wide perspective. The pharmaceutical business is preparing for the launch of a biopharmaceutical CDMO site for dual-use manufacturing. The company is also leveraging its iPS cell and AI technologies in the contract research organization (CRO) business. In FY2026, the company incurred an expenditure of JPY157,790 million on R&D, which as a percentage of revenue, stood at 4.7%.
Business Segments
Overview
Comprises business solutions, office solutions and graphic communications. Provides products and services that support work style innovation and digital transformation.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Offers advanced materials for industries such as semiconductors, display and touch panels, and functional films. Also offers storage media and archiving services.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Provides medical devices, bio CDMO services, pharmaceuticals, regenerative medicine, and life sciences products. It focuses on prevention, diagnosis, and treatments. The segment also provides equipment and materials for medical systems, contract development and manufacturing organization of biopharmaceuticals, iPS cells (regenerative medicine), drug discovery support such as cell culture media and reagents, pharmaceuticals, cosmetics, and supplements.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Provides products and services from input to output, including color films, instant cameras, developing and printing systems, color paper, and photo printing services. It serves the consumer and professional imaging industries.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Geographical Segments
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Target Markets
Japan
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer